Skip to content

13F-HR filed by GREAT POINT PARTNERS LLC

GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:15:48 UTC, with 45 holding rows worth $418,469,943.

Accession
0001172661-26-005345
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 45 entries on the cover page, a total value of $418,469,943 stated on the cover page (in dollars after the unit check, H1), rows summing to $418,469,943 with VALUE read as dollars as filed, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IMMUNITYBIO INC45256X103COM3,000,800$28,327,552dollars as filedput
VERA THERAPEUTICS INC92337R101COMMON STOCK808,717$26,113,472dollars as filed
VOR BIOPHARMA INC929033207COMMON STOCK1,126,910$21,501,443dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM700,000$20,370,000dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK1,961,701$19,381,606dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS508,735$19,362,454dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock420,000$18,753,000dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share525,000$18,729,375dollars as filed
SOL-GEL TECHNOLOGIES LTDM8694L137SHS NEW239,159$17,764,731dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK4,077,256$16,961,385dollars as filed
LB PHARMACEUTICALS INC50180M108COMMON STOCK410,420$15,751,920dollars as filed
ABIVAX SA-00370M103SPONSORED ADS155,000$15,348,100dollars as filed
ANNEXON INC03589W102COM3,500,000$14,805,000dollars as filed
BELITE BIO INC07782B104CMN75,000$12,736,500dollars as filed
EUPRAXIA PHARMACEUTICALS INC29842P105COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/11,200,000$10,920,000dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK175,000$10,595,375dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock855,813$10,013,012dollars as filed
CLIMB BIO INC28658R106COMMON STOCK800,000$9,176,000dollars as filed
ABCELLERA BIOLOGICS INC COM00288U106Stock600,000$8,754,000dollars as filed
NEUROGENE INC64135M105COMMON STOCK300,000$8,346,000dollars as filed
COMPASS PATHWAYS PLC20451W101SPONSORED ADS500,000$6,220,000dollars as filed
JATT II ACQUISITION CORPG50765109ORD SHS500,000$5,622,500dollars as filed
Inflarx NvN44821101COM3,046,557$5,483,803dollars as filed
Research Alliance Corp Iii Ord Shs Cl AG75226103Common Stock504,891$5,467,970dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK109,603$5,460,421dollars as filed
AMANAT ACQUISITION CORPG0375M101CL A ORD500,000$5,340,000dollars as filed
ALTIMMUNE INC02155H200COM NEW1,741,232$4,979,924dollars as filed
JATT III ACQUISITION CORPG5080G109COM450,000$4,959,000dollars as filed
PHARVARIS NVN69605108COMMON STOCK150,000$4,758,000dollars as filedput
SCYNEXIS INC811292309COM944,292$4,664,802dollars as filed
CULLINAN THERAPEUTICS INC230031106COM300,000$4,605,000dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock300,000$4,026,000dollars as filedcall
CYBIN INC23256X407COM NEW320,952$3,944,500dollars as filed
REZOLUTE INC76200L309COMMON STOCK951,809$3,940,489dollars as filed
OPUS GENETICS INC67577R102COMMON STOCK776,881$3,760,104dollars as filed
ENLIVEN THERAPEUTICS INC COM29337E102Stock70,000$3,208,800dollars as filed
RELMADA THERAPEUTICS INC75955J402COMMON STOCK842,106$3,174,740dollars as filed
DBV TECHNOLOGIES S A23306J309SPONSORED ADS250,000$2,940,000dollars as filed
EVOMMUNE INC30054Y107COMMON STOCK325,000$2,684,500dollars as filed
CONTINEUM THERAPEUTICS INC CL A21217B100Stock186,183$2,498,576dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock24,649$2,053,015dollars as filed
HUMACYTE INC44486Q103COM3,750,000$1,941,375dollars as filed
REIN THERAPEUTICS INC00887A204COM NEW1,663,144$1,337,168dollars as filed
RESEARCH ALLIANCE CORP IVG75228109CL A ORD SHS106,396$1,276,752dollars as filed
ANNEXON INC03589W102COM97,300$411,579dollars as filedcall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-26-005345this filing2026-11-16